Inhaled nitric oxide in infants with developing or established chronic lung disease

Area of Science:

• Neonatology
• Pediatric Pulmonology
• Critical Care Medicine

Background:

• Chronic lung disease (CLD) in infants often leads to impaired gas exchange.
• Ventilator-dependent infants with CLD frequently present with pathological oxygenation.
• Optimizing oxygenation is crucial for improving outcomes in these vulnerable patients.

Purpose of the Study:

• To investigate the effect of inhaled nitric oxide (iNO) on gas exchange in ventilator-dependent infants with CLD.
• To determine the optimal concentration of iNO for improving oxygenation.
• To assess the safety and tolerability of iNO in this patient population.

Main Methods:

• Nine ventilator-dependent infants with CLD received inhaled nitric oxide at increasing concentrations (0-60 ppm).
• Gas exchange was monitored using arterial or transcutaneous PO2/PCO2 measurements.
• Methaemoglobin levels, blood pressure, and heart rate were assessed for safety.

Main Results:

• Inhaled nitric oxide significantly improved oxygenation, evidenced by a reduced oxygenation index (p < 0.014).
• Optimal iNO concentration and individual responses varied among patients.
• No significant changes in PCO2, methaemoglobin, blood pressure, or heart rate were observed.

Conclusions:

• Inhaled nitric oxide demonstrates potential as a therapeutic agent for improving oxygenation in ventilator-dependent infants with CLD.
• The efficacy and safety of iNO vary individually, necessitating further investigation.
• Long-term studies are required to establish the sustained efficacy and safety profile of iNO for prolonged use in this patient group.